Currently Recruiting Clinical Trials

Currently Recruiting Clinical Trials are listed below. If you have any questions about our current research, please contact our research department at research@hurongastro.com or call 734-961-6768.

• A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Subjects with Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH) (GS-US-454-6075) 

• In Active Ulcerative Colitis- A Randomized Controlled Trial for Determination of the Optimal Treatment Target (Treatment algorithms will feature the use of vedolizumab) (VERDICT, RP-1706)

• A Study to Assess the Genotype of Subjects with Diagnosis of Ulcerative Colitis or Crohn’s Disease (PRELUDE PR100-105)

• A Phase 2/3, Randomized, Double-Blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease (GALAXI, CNTO1959CRD3001)